>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Air Products (APD) upgraded to Buy from Neutral at UBS; tgt $375
    • Amylyx Pharmaceuticals (AMLX) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $11
    • Autolus Therapeutics (AUTL) upgraded to Buy from Neutral at Goldman; tgt raised to $7.60
    • Bright Horizons (BFAM) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt lowered to $125
    • CVS Health (CVS) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $66
    • Hewlett Packard Enterprise (HPE) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $29
    • MBIA (MBI) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $9
    • Moderna (MRNA) upgraded to Buy from Hold at HSBC Securities; tgt $58
    • Monolithic Power (MPWR) upgraded to Buy from Hold at Loop Capital; tgt $660
    • Robinhood Markets (HOOD) upgraded to Buy from Hold at Needham; tgt $40
    • Roku (ROKU) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $90
    • United Fire Group (UFCS) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $26
  • Downgrades:
    • Avis Budget (CAR) downgraded to Neutral from Buy at Northcoast
    • Biogen (BIIB) downgraded to Hold from Buy at Needham
    • Crane (CR) downgraded to Hold from Buy at Stifel; tgt $176
    • Curtiss-Wright (CW) downgraded to Hold from Buy at Stifel; tgt $370
    • EOG Resources (EOG) downgraded to Neutral from Overweight at Piper Sandler; tgt raised to $149
    • ESAB Corp. (ESAB) downgraded to Hold from Buy at Stifel; tgt lowered to $130
    • Eyenovia (EYEN) downgraded to Neutral from Buy at H.C. Wainwright; tgt lowered to $2
    • FB Financial (FBK) downgraded to Market Perform from Outperform at Hovde Group; tgt $60
    • Ingersoll-Rand (IR) downgraded to Hold from Buy at Stifel; tgt lowered to $107
    • Liberty Global (LBTYA) downgraded to Neutral from Buy at UBS; tgt lowered to $13
    • Matson (MATX) downgraded to Peer Perform from Outperform at Wolfe Research
    • National Bank (NBHC) downgraded to Market Perform from Outperform at Hovde Group; tgt $55
    • Parker-Hannifin (PH) downgraded to Hold from Buy at Stifel; tgt $691
    • Pinnacle Finl (PNFP) downgraded to Market Perform from Outperform at Hovde Group; tgt $135
    • Pinnacle West (PNW) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $91
    • Redfin (RDFN) downgraded to Sell from Neutral at Goldman; tgt raised to $6.50
  • Others:
    • Akero Therapeutics (AKRO) initiated with a Buy at Citigroup; tgt $65
    • Astera Labs (ALAB) initiated with a Buy at Citigroup; tgt $120
    • Capricor Therapeutics (CAPR) initiated with a Buy at JonesResearch
    • enGene Holdings (ENGN) initiated with a Mkt Outperform at JMP Securities; tgt $18
    • Erasca (ERAS) initiated with a Buy at Jefferies; tgt $6
    • GATX (GATX) initiated with a Buy at Goldman; tgt $185
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Loop Capital; tgt $30
    • Ingram Micro Holding Corp. (INGM) initiated with an Outperform at Raymond James; tgt $28
    • Ingram Micro Holding Corp. (INGM) initiated with an Equal-Weight at Morgan Stanley; tgt $24
    • Ingram Micro Holding Corp. (INGM) initiated with a Neutral at Exane BNP Paribas; tgt $25
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Stifel; tgt $28
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Deutsche Bank; tgt $26
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at BofA Securities; tgt $30
    • Ingram Micro Holding Corp. (INGM) initiated with an Outperform at RBC Capital Mkts; tgt $26
    • Ingram Micro Holding Corp. (INGM) initiated with an In-line at Evercore ISI; tgt $27
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Jefferies; tgt $28
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Redburn Atlantic; tgt $30
    • Korro Bio (KRRO) initiated with a Buy at JonesResearch
    • Penguin Solutions (PENG) initiated with a Mkt Outperform at JMP Securities; tgt $23
    • RXO, Inc. (RXO) resumed with a Neutral at Goldman; tgt $29
    • TechnipFMC (FTI) initiated with an Outperform at RBC Capital Mkts; tgt $37
    • Trinity Industries (TRN) initiated with a Neutral at Goldman; tgt $39
    • VYNE Therapeutics (VYNE) initiated with a Buy at BTIG Research; tgt $8